|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Impairment loss on other intangible assets | |||||
| Merger-related expenses | |||||
| Restructuring and other expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on settlement of current liabilities | |||||
| Loss on debt extinguishment | |||||
| Change in fair value of warrant liabilities | |||||
| Loss on derivative liability | |||||
| Foreign currency exchange gains (losses), net | |||||
| Other expense, net | |||||
| Total other income, net | |||||
| Net loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Other comprehensive income, net of tax: | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive income, net of tax | |||||
| Total comprehensive loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted-average number of Ordinary Shares used in computing net loss per share - basic | |||||
| Weighted-average number of Ordinary Shares used in computing net loss per share - diluted | |||||
Loading...